Yahoo
NasdaqCM - Nasdaq Real Time Price USD

OptimizeRx Corporation (OPRX)

9.41 +0.09 (+0.97%)
At close: November 2 at 4:00:00 PM EST
9.30 -0.11 (-1.17%)
After hours: November 2 at 6:29:56 PM EST
Trade OPRX on Coinbase
Chart Range Bar
Loading chart for OPRX
Chart does not reflect overnight price.
  • Previous Close 9.32
  • Open 9.48
  • Bid 6.90 x 200
  • Ask 11.95 x 200
  • Day's Range 9.30 - 9.64
  • 52 Week Range 4.54 - 21.09
  • Volume 148,278
  • Avg. Volume 180,417
  • Market Cap (intraday) 177.246M
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) 39.21
  • EPS (TTM) 0.24
  • Earnings Date Nov 11, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 12.60
  • Zacks Rating Bearish

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

www.optimizerx.com

132

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OPRX
23.25%
S&P 500 (^GSPC)
10.17%

1-Year Return

OPRX
54.08%
S&P 500 (^GSPC)
10.25%

3-Year Return

OPRX
13.24%
S&P 500 (^GSPC)
74.66%

5-Year Return

OPRX
90.24%
S&P 500 (^GSPC)
62.86%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 32.24M
Earnings 5.02M
Profit Margin 15.57%

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

0
10M
20M
30M
-10.0%
-5.0%
0.0%
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

11.00
12.60 Average
9.41 Current
18.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/29/2026
Analyst B. Riley Securities
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 10 -> 11

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    175.55M

  • Enterprise Value

    170.94M

  • Trailing P/E

    38.83

  • Forward P/E

    6.90

  • PEG Ratio (current)

    1.05

  • Price/Sales (ttm)

    1.81

  • Price/Book (mrq)

    1.34

  • Enterprise Value/Revenue

    1.73

  • Enterprise Value/EBITDA

    11.09

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.66%

  • Return on Assets (ttm)

    4.22%

  • Return on Equity (ttm)

    3.67%

  • Revenue (ttm)

    98.65M

  • Net Income Avi to Common (ttm)

    4.6M

  • Diluted EPS (ttm)

    0.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    24.1M

  • Total Debt/Equity (mrq)

    14.86%

  • Levered Free Cash Flow (ttm)

    15.76M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

9.41 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Lowering target price to $10.00

    OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

  • Lowering target price to $13.00

    OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

  • What does Argus have to say about OPRX?

    OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

  • What does Argus have to say about OPRX?

    OPTIMIZERX CORP has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: